Loss of Cyp8b1 improves glucose homeostasis by increasing GLP-1

Diabetes

Volumn 64, Issue 4, 2015, Pages 1168-1179

  Kaur, Achint ^a   Patankar, Jay V ^a   De Haan, Willeke ^a   Ruddle, Piers ^a   Wijesekara, Nadeeja ^a   Groen, Albert K ^b   Verchere, C Bruce ^c   Singaraja, Roshni R ^d   Hayden, Michael R ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^c UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^d NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL 7ALPHA MONOOXYGENASE; CHOLIC ACID; FATTY ACID; GLUCAGON LIKE PEPTIDE 1; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; STEROID 12ALPHA MONOOXYGENASE; TRIACYLGLYCEROL; URSODEOXYCHOLIC ACID; GASTRIC INHIBITORY POLYPEPTIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL FUNCTION; CONTROLLED STUDY; ENZYME INHIBITION; FEMALE; GENE EXPRESSION; GLUCOSE HOMEOSTASIS; GLUCOSE METABOLISM; GLUCOSE TOLERANCE; GLYCEMIC CONTROL; INSULIN RELEASE; INSULIN SENSITIVITY; INSULIN SYNTHESIS; L CELL LINE; LIPID ABSORPTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; ANIMAL; GENETICS; HOMEOSTASIS; INSULIN RESISTANCE; KNOCKOUT MOUSE; METABOLISM; PANCREAS ISLET BETA CELL; PHYSIOLOGY;

ANIMALS; CHOLIC ACID; GASTRIC INHIBITORY POLYPEPTIDE; GLUCAGON-LIKE PEPTIDE 1; GLUCOSE; HOMEOSTASIS; INSULIN; INSULIN RESISTANCE; INSULIN-SECRETING CELLS; MICE; MICE, KNOCKOUT; STEROID 12-ALPHA-HYDROXYLASE;

EID: 84929512500     PISSN: 00121797     EISSN: 1939327X     Source Type: Journal    
DOI: 10.2337/db14-0716     Document Type: Article

References (38)

1. Staels B, Fonseca VA. Bile acids and metabolic regulation: Mechanisms and clinical responses to bile acid sequestration. Diabetes Care 2009;32(Suppl. 2): S237-S245
2. Botham KM, Boyd GS. The metabolism of chenodeoxycholic acid to betamuricholic acid in rat liver. Eur J Biochem 1983;134: 191-196
3. Li-Hawkins J, Gåfvels M, Olin M, et al. Cholic acid mediates negative feedback regulation of bile acid synthesis in mice. J Clin Invest 2002;110: 1191-1200
4. Murphy C, Parini P, Wang J, Björkhem I, Eggertsen G, Gåfvels M. Cholic acid as key regulator of cholesterol synthesis, intestinal absorption and hepatic storage in mice. Biochim Biophys Acta 2005;1735: 167-175
5. Wang J, Gåfvels M, Rudling M, et al. Critical role of cholic acid for development of hypercholesterolemia and gallstones in diabetic mice. Biochem Biophys Res Commun 2006;342: 1382-1388
6. Wang J, Einarsson C, Murphy C, et al. Studies on LXR-and FXR-mediated effects on cholesterol homeostasis in normal and cholic acid-depleted mice. J Lipid Res 2006;47: 421-430
7. Slätis K, Gåfvels M, Kannisto K, et al. Abolished synthesis of cholic acid reduces atherosclerotic development in apolipoprotein E knockout mice. J Lipid Res 2010;51: 3289-3298
8. Trauner M, Claudel T, Fickert P, Moustafa T, Wagner M. Bile acids as regulators of hepatic lipid and glucose metabolism. Dig Dis 2010;28: 220-224
9. Katsuma S, Hirasawa A, Tsujimoto G. Bile acids promote glucagon-like peptide-1 secretion through TGR5 in a murine enteroendocrine cell line STC-1. Biochem Biophys Res Commun 2005;329: 386-390
10. Thomas C, Gioiello A, Noriega L, et al. TGR5-mediated bile acid sensing controls glucose homeostasis. Cell Metab 2009;10: 167-177
11. Gedulin BR, Nikoulina SE, Smith PA, et al. Exenatide (exendin-4) improves insulin sensitivity and beta-cell mass in insulin-resistant obese fa/fa Zucker rats independent of glycemia and body weight. Endocrinology 2005;146: 2069-2076
12. Knop FK. Bile-induced secretion of glucagon-like peptide-1: Pathophysiological implications in type 2 diabetes? Am J Physiol Endocrinol Metab 2010;299: E10-E13
13. Potthoff MJ, Potts A, He T, et al. Colesevelam suppresses hepatic glycogenolysis by TGR5-mediated induction of GLP-1 action in DIO mice. Am J Physiol Gastrointest Liver Physiol 2013;304: G371-G380
14. Hofmann AF. Bile acid sequestrants improve glycemic control in type 2 diabetes: A proposed mechanism implicating glucagon-like peptide 1 release. Hepatology 2011;53: 1784
15. Hulzebos CV, Renfurm L, Bandsma RH, et al. Measurement of parameters of cholic acid kinetics in plasma using a microscale stable isotope dilution technique: Application to rodents and humans. J Lipid Res 2001;42: 1923-1929
16. Keane MH, Overmars H, Wikander TM, et al. Bile acid treatment alters hepatic disease and bile acid transport in peroxisome-deficient PEX2 Zellweger mice. Hepatology 2007;45: 982-997
17. Folch J, Lees M, Sloane Stanley GH. A simple method for the isolation and purification of total lipides from animal tissues. J Biol Chem 1957;226: 497-509
18. Hardy AB, Wijesekara N, Genkin I, et al. Effects of high-fat diet feeding on Znt8-null mice: Differences between β-cell and global knockout of Znt8. Am J Physiol Endocrinol Metab 2012;302: E1084-E1096.
19. Kruit JK, Wijesekara N, Fox JE, et al. Islet cholesterol accumulation due to loss of ABCA1 leads to impaired exocytosis of insulin granules. Diabetes 2011; 60: 3186-3196
20. Haeusler RA, Astiarraga B, Camastra S, Accili D, Ferrannini E. Human insulin resistance is associated with increased plasma levels of 12a-hydroxylated bile acids. Diabetes 2013;62: 4184-4191
21. Li T, Owsley E, Matozel M, Hsu P, Novak CM, Chiang JY. Transgenic expression of cholesterol 7alpha-hydroxylase in the liver prevents high-fat dietinduced obesity and insulin resistance in mice. Hepatology 2010;52: 678-690
22. Nauck M, Stöckmann F, Ebert R, Creutzfeldt W. Reduced incretin effect in type 2 (non-insulin-dependent) diabetes. Diabetologia 1986;29: 46-52
23. Hirasawa A, Tsumaya K, Awaji T, et al. Free fatty acids regulate gut incretin glucagon-like peptide-1 secretion through GPR120. Nat Med 2005;11: 90-94
24. Fehmann HC, Habener JF. Insulinotropic hormone glucagon-like peptide-I(7-37) stimulation of proinsulin gene expression and proinsulin biosynthesis in insulinoma beta TC-1 cells. Endocrinology 1992;130: 159-166
25. Xu G, Stoffers DA, Habener JF, Bonner-Weir S. Exendin-4 stimulates both beta-cell replication and neogenesis, resulting in increased beta-cell mass and improved glucose tolerance in diabetic rats. Diabetes 1999;48: 2270-2276
26. Perfetti R, Zhou J, Doyle ME, Egan JM. Glucagon-like peptide-1 induces cell proliferation and pancreatic-duodenum homeobox-1 expression and increases endocrine cell mass in the pancreas of old, glucose-intolerant rats. Endocrinology 2000;141: 4600-4605
27. Sathananthan M, Farrugia LP, Miles JM, et al. Direct effects of exendin-(9,39) and GLP-1-(9,36)amide on insulin action, β-cell function, and glucose metabolism in nondiabetic subjects. Diabetes 2013;62: 2752-2756
28. Hu X, Bonde Y, Eggertsen G, Rudling M. Muricholic bile acids are potent regulators of bile acid synthesis via a positive feedback mechanism. J Intern Med 2014;275: 27-38
29. Pols TW, Noriega LG, Nomura M, Auwerx J, Schoonjans K. The bile acid membrane receptor TGR5 as an emerging target in metabolism and inflammation. J Hepatol 2011;54: 1263-1272
30. Matysik S, Martin J, Bala M, Scherer M, Schäffler A, Schmitz G. Bile acid signaling after an oral glucose tolerance test. Chem Phys Lipids 2011;164: 525-529
31. Tan KP, Wood GA, Yang M, Ito S. Participation of nuclear factor (erythroid 2-related), factor 2 in ameliorating lithocholic acid-induced cholestatic liver injury in mice. Br J Pharmacol 2010;161: 1111-1121
32. Idris I, Patiag D, Gray S, Donnelly R. Exendin-4 increases insulin sensitivity via a PI-3-kinase-dependent mechanism: Contrasting effects of GLP-1. Biochem Pharmacol 2002;63: 993-996
33. Zander M, Madsbad S, Madsen JL, Holst JJ. Effect of 6-week course of glucagon-like peptide 1 on glycaemic control, insulin sensitivity, and beta-cell function in type 2 diabetes: A parallel-group study. Lancet 2002;359: 824-830
34. Steiner A, Howard E, Akgun S. Effect of antibiotics on the serum cholesterol concentration of patients with atherosclerosis. Circulation 1961;24: 729-735
35. Sayin SI, Wahlström A, Felin J, et al. Gut microbiota regulates bile acid metabolism by reducing the levels of tauro-beta-muricholic acid, a naturally occurring FXR antagonist. Cell Metab 2013;17: 225-235
36. Caesar R, Reigstad CS, Bäckhed HK, et al. Gut-derived lipopolysaccharide augments adipose macrophage accumulation but is not essential for impaired glucose or insulin tolerance in mice. Gut 2012;61: 1701-1707
37. Düfer M, Hörth K, Wagner R, et al. Bile acids acutely stimulate insulin secretion of mouse β-cells via farnesoid X receptor activation and K(ATP) channel inhibition. Diabetes 2012;61: 1479-1489
38. Kumar DP, Rajagopal S, Mahavadi S, et al. Activation of transmembrane bile acid receptor TGR5 stimulates insulin secretion in pancreatic β cells. Biochem Biophys Res Commun 2012;427: 600-605